Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices 3909 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Family History 

and Diamond Blackfan Anemia, DD11– 

010, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date 

11 a.m.–5 p.m., April 19, 2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Family History and Diamond 

Blackfan Anemia, DD11–010, initial review.’’ 

Contact Person for More Information: 

Michael Dalmat, DrPH, Scientific Review 

Officer, CDC, National Center for Chronic 

Disease Prevention and Health Promotion, 

Office of the Director, Extramural Research 

Program Office, 4770 Buford Highway, NE., 

Mailstop K–92, Atlanta, GA 30341, 

Telephone: (770) 488–6423, E-mail: 

MED1@CDC.GOV. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: January 7, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–1233 Filed 1–20–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC)—Ethics 

Subcommittee (ES) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned subcommittee: 

Times and Dates: 

1 p.m.–5 p.m., February 17, 2011; 8:30 

a.m.–12:30 p.m., February 18, 2011. 

Place: CDC, Thomas R. Harkin Global 

Communications Center, Distance 

Learning Auditorium, 1600 Clifton 

Road, NE., Atlanta, GA 30333. This 

meeting is also available by 

teleconference. Please dial (877) 

928–1204 and enter code 4305992. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 60 

people. To accommodate public 

participation in the meeting, a 

conference telephone line will be 

available. The public is welcome to 

participate during the public comment. 

The public comment periods are 

tentatively scheduled for 4 p.m.–4:15 

p.m. on February 17, 2011 and from 

12 p.m.–12:15 p.m. on February 18, 

2011. 

Purpose: The ES will provide counsel 

to the ACD, CDC, regarding a broad 

range of public health ethics questions 

and issues arising from programs, 

scientists and practitioners. 

Matter To Be Discussed: Agenda items 

will include the following: A review of 

public comments submitted on the 

ethical considerations document for the 

allocation of ventilators during a severe 

pandemic; finalizing the presentation 

for the ACD on ethical issues related to 

non-communicable disease prevention 

and control; and a review of the 

outcome of discussions with state, 

tribal, local, and territorial health 

officers on public health ethics 

challenges, including an assessment of 

available options towards the 

development of practical tools to assist 

health departments in their efforts to 

address these challenges. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

For security reasons, members of the 

public interested in attending the 

meeting should contact Drue Barrett, 

PhD, Designated Federal Officer, ACD, 

CDC–ES, 1600 Clifton Road, NE., M/S 

D–50, Atlanta, Georgia 30333. 

Telephone (404) 639–4690. E-mail: 

dbarrett@cdc.gov. The deadline for 

notification of attendance is February 

11, 2011. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: January 14, 2011. 

Lorenzo J. Falgiano, 

Acting Director, Management Analysis and 

Service Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2011–1232 Filed 1–20–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–R–148, CMS–R– 

266, and CMS–216] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Limitations on 

Provider Related Donations and Health 

Care Related Taxes; Limitation on 

Payments for Disproportionate Share 

Hospitals and Supporting Regulations in 

42 CFR 433.68, 433.74 and 447.272; 

Use: This information collection is 

necessary to ensure compliance with 

Sections 1903 and 1923 of the Social 

Security Act for the purpose of 

preventing payments of Federal 

financial participation on amounts 

prohibited by statute; Form Number: 

CMS–R–148 (OMB#: 0938–0618); 

Frequency: Quarterly and occasionally; 

Affected Public: State, Local, or Tribal 

Governments; Number of Respondents: 

50; Total Annual Responses: 40; Total 

Annual Hours: 3,200. (For policy 

questions regarding this collection 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

3910 Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices 

contact Rory Howe at 410–786–4878. 

For all other issues call 410–786–1326.) 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medicaid 

Disproportionate Share Hospital Annual 

Reporting; Use: Section 1923(j)(i) of the 

Social Security Act requires States to 

submit an annual report that identifies 

each disproportionate share hospital 

(DSH) that received a DSH payment 

under the State’s Medicaid program in 

the preceding fiscal year and the 

amount of DSH payments paid to that 

hospital in the same year and such other 

information as the Secretary determines 

necessary to ensure the appropriateness 

of DSH payments. The information 

supplied will also satisfy the 

requirements under section 

1923(a)(2)(D) of the Act; Form Number: 

CMS–R–266 (OMB#: 0938–0746); 

Frequency: Yearly; Affected Public: 

State, Local, or Tribal Governments; 

Number of Respondents: 52; Total 

Annual Responses: 52; Total Annual 

Hours: 1,976. (For policy questions 

regarding this collection contact Rory 

Howe at 410–786–4878. For all other 

issues call 410–786–1326.) 

3. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Organ 

Procurement Organization/ 

Histocompatibility Laboratory 

Statement of Reimbursable Costs, 

manual instructions and supporting 

regulations contained in 42 CFR 413.20 

and 413.24; Use: This form is required 

by the statute and regulation for 

participation in the Medicare program. 

The information is used to determine 

payment for Medicare. Organ 

Procurement Organizations and 

Histocompatibility Laboratories are the 

users. Form Number: CMS–216–94 

(OMB# 0938–0102); Frequency: Yearly; 

Affected Public: Business or other forprofit, not-for-profit institutions; 

Number of Respondents: 115; Total 

Annual Responses: 115; Total Annual 

Hours: 5,175. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by March 22, 2011: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

Martique Jones, 

Director, Regulations Development Group, 

Division B, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2011–1265 Filed 1–20–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0015] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Orphan Drugs; 

Common European Medicines Agency/ 

Food and Drug Administration 

Application Form for Orphan Medicinal 

Product Designation (Form FDA 3671) 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the procedures by which sponsors of 

orphan drugs may request eligibility for 

the incentives by implementing a 

program as outlined in the Orphan Drug 

Act and the joint adoption by FDA and 

the European Medicines Agency (EMA) 

of the Common EMA/FDA Application 

Form for Orphan Medicinal Product 

Designation (form FDA 3671). 

DATES: Submit either electronic or 

written comments on the collection of 

information by March 22, 2011. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http:// 

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of Information 

Management, Food and Drug 

Administration, 1350 Piccard Dr., PI50– 

400B, Rockville, MD 20850. 301–796– 

3794. Jonnalynn.Capezzuto@ 

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined in 

44 U.S.C. 3502(3) and 5 CFR 1320.3(c) 

and includes Agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal Agencies 

to provide a 60-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES